F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Metabolic associated fatty liver disease

Page 1 of 1 ( 26 items )
<<
1
>>

1	Metabolically associated fatty liver disease: What hepatologists need to know about this systemic disease 3/26/2026 9:22:57 AM \| Browse: 70 \| Download: 131
2	Metabolic dysfunction-associated fatty liver disease: A key player in colorectal cancer development and progression 3/10/2026 6:59:26 AM \| Browse: 133 \| Download: 377
3	Prevalence of metabolic dysfunction-associated fatty liver disease among health check-up attendees: A retrospective study conducted in Vietnam 9/25/2025 3:33:10 AM \| Browse: 381 \| Download: 675
4	Fibrinogen superfamily proteins: Key regulators in hepatic disorders 8/12/2025 8:18:27 AM \| Browse: 146 \| Download: 676
5	Immune cells in metabolic associated fatty liver disease: Global trends and hotspots (2004-2024) 3/26/2025 4:06:55 AM \| Browse: 489 \| Download: 879
6	Association of Life’s Essential 8 and Life’s Simple 7 with metabolic-associated fatty liver disease in the United States 2/20/2025 8:40:19 AM \| Browse: 287 \| Download: 891
7	Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need 7/1/2024 7:39:37 AM \| Browse: 427 \| Download: 855
8	Manipulation of the intestinal microbiome-a slow journey to primetime 7/27/2023 1:26:07 AM \| Browse: 440 \| Download: 1382
9	Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes 4/20/2023 7:26:29 AM \| Browse: 502 \| Download: 1419
10	Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate 2/24/2023 1:35:50 PM \| Browse: 629 \| Download: 1510
11	Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19 9/29/2022 10:42:42 AM \| Browse: 1044 \| Download: 3071
12	Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? 9/23/2022 12:48:56 AM \| Browse: 921 \| Download: 1704
13	Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B 8/26/2022 9:51:35 AM \| Browse: 718 \| Download: 2235
14	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 939 \| Download: 2371
15	Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease 2/9/2022 7:25:27 AM \| Browse: 830 \| Download: 1972
16	Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? 1/21/2022 8:16:14 AM \| Browse: 809 \| Download: 1735
17	Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis 12/27/2021 5:24:00 AM \| Browse: 1060 \| Download: 2451
18	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 1026 \| Download: 2321
19	Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease 9/9/2021 6:46:56 AM \| Browse: 963 \| Download: 2537
20	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 1071 \| Download: 1713
21	Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence 8/20/2021 9:33:19 AM \| Browse: 1074 \| Download: 2338
22	Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease 8/10/2021 6:48:42 AM \| Browse: 988 \| Download: 1771
23	Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic associated fatty liver disease 4/9/2021 9:07:56 AM \| Browse: 1202 \| Download: 2787
24	Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection 1/25/2021 6:05:27 AM \| Browse: 891 \| Download: 2678
25	Metabolic associated fatty liver disease: Addressing a new era in liver transplantation 12/18/2020 5:58:43 AM \| Browse: 1241 \| Download: 1964
26	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 1394 \| Download: 2124

Page 1 of 1 ( 26 items )
<<
1
>>

1	Metabolically associated fatty liver disease: What hepatologists need to know about this systemic disease 3/26/2026 9:22:57 AM \| Browse: 70 \| Download: 131
2	Metabolic dysfunction-associated fatty liver disease: A key player in colorectal cancer development and progression 3/10/2026 6:59:26 AM \| Browse: 133 \| Download: 377
3	Prevalence of metabolic dysfunction-associated fatty liver disease among health check-up attendees: A retrospective study conducted in Vietnam 9/25/2025 3:33:10 AM \| Browse: 381 \| Download: 675
4	Fibrinogen superfamily proteins: Key regulators in hepatic disorders 8/12/2025 8:18:27 AM \| Browse: 146 \| Download: 676
5	Immune cells in metabolic associated fatty liver disease: Global trends and hotspots (2004-2024) 3/26/2025 4:06:55 AM \| Browse: 489 \| Download: 879
6	Association of Life’s Essential 8 and Life’s Simple 7 with metabolic-associated fatty liver disease in the United States 2/20/2025 8:40:19 AM \| Browse: 287 \| Download: 891
7	Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need 7/1/2024 7:39:37 AM \| Browse: 427 \| Download: 855
8	Manipulation of the intestinal microbiome-a slow journey to primetime 7/27/2023 1:26:07 AM \| Browse: 440 \| Download: 1382
9	Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes 4/20/2023 7:26:29 AM \| Browse: 502 \| Download: 1419
10	Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate 2/24/2023 1:35:50 PM \| Browse: 629 \| Download: 1510
11	Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19 9/29/2022 10:42:42 AM \| Browse: 1044 \| Download: 3071
12	Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? 9/23/2022 12:48:56 AM \| Browse: 921 \| Download: 1704
13	Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B 8/26/2022 9:51:35 AM \| Browse: 718 \| Download: 2235
14	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 939 \| Download: 2371
15	Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease 2/9/2022 7:25:27 AM \| Browse: 830 \| Download: 1972
16	Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? 1/21/2022 8:16:14 AM \| Browse: 809 \| Download: 1735
17	Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis 12/27/2021 5:24:00 AM \| Browse: 1060 \| Download: 2451
18	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 1026 \| Download: 2321
19	Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease 9/9/2021 6:46:56 AM \| Browse: 963 \| Download: 2537
20	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 1071 \| Download: 1713
21	Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence 8/20/2021 9:33:19 AM \| Browse: 1074 \| Download: 2338
22	Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease 8/10/2021 6:48:42 AM \| Browse: 988 \| Download: 1771
23	Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic associated fatty liver disease 4/9/2021 9:07:56 AM \| Browse: 1202 \| Download: 2787
24	Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection 1/25/2021 6:05:27 AM \| Browse: 891 \| Download: 2678
25	Metabolic associated fatty liver disease: Addressing a new era in liver transplantation 12/18/2020 5:58:43 AM \| Browse: 1241 \| Download: 1964
26	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 1394 \| Download: 2124